UK Stock News
Everyman Media Group Names Interim CEO as Alex Scrimgeour Steps Down
Everyman Media Group (LON: EMAN) has announced a leadership change, with Chief Executive Alex Scrimgeour stepping down from his role with immediate effect. The news c
Metals One Gains Exposure to South African Gold Play Through Lions Bay Resources’ Vantage Bid
Metals One Plc (AIM: MET1, OTCQB: MTOPF) shares rose over 7% on Monday after the company said it is positioned to benefit from a potential vertically integrated gold business in South Africa, following an offer by Lions Bay R
Invinity Energy Systems Secures First Endurium Enterprise Order
Invinity Energy Systems plc (AIM: IES), a vanadium flow battery manufacturer, announced its first sale of the Endurium Enterprise system. The 3.5 MWh system will be deploy
Tooru Refinances Debt Facility, Eyes Growth in Health and Wellness Sector
Tooru PLC (TOO.LN), an AIM-listed company focused on branded health and wellness, provided a trading and financing update, signaling a year of progress following its reverse takeover in May 2025. The company is focused on agg
IPF Set for Acquisition by IPF Parent Holdings in £543 Million Deal
International Personal Finance Plc (IPF) is poised to be acquired by IPF Parent Holdings Limited (Bidco), a newly formed entity within the BasePoint Capital LLC group. The recommended cash acquisition values IPF at approximat
FTSE 100 Lower; BP to Sell Majority Stake in Castrol, GBP/USD Rises Above 1.35
The FTSE 100 slipped 0.2% on Christmas Eve during a shortened trading session across several European markets, with Paris and Amsterdam also operating half days. France’s
GMS Secures New Middle East Contract, Corrects Previous Announcement
Gulf Marine Services PLC (LON: GMS) has announced a new contract award for one of its Large-class vessels in the Middle East, providing a boost to its backlog and affirming strong demand for its services. Simultaneously, the
Defence Holdings (ALRT) Agrees Appointment of New CEO
Defence Holdings PLC (LSE: ALRT), a UK-listed defence technology group, has announced the appointment of a new Chief Executive Officer, marking a significant step in the company's transition from capability development to com
Supermarket Income REIT Expands Portfolio with £98 Million Acquisition
Supermarket Income REIT (LON: SUPR) has announced the acquisition of three UK supermarkets for £97.6 million, reflecting an average net initial yield of 5.5%. The move aligns with SUPR's strategy to enhance earnings through w
BP Sells Majority Stake in Castrol to Stonepeak for $10 Billion, Shares Stable
BP (LON: BP) has reached an agreement to sell a 65% shareholding in its Castrol lubricants business to Stonepeak, valuing Castrol at an enterprise value of $10.1 billion. [st
FTSE 100 Edges Higher; PETS Appoints New CEO, Metlen Energy & Metals Shares Rise
The FTSE 100 edged up 0.1% on Tuesday, supported by selective corporate gains, while broader European markets delivered a mixed performance. Germany’s DAX was flat, France
Carnival Shares: Analysts Remain Bullish Following Strong Q4
Carnival (LON: CCL) (NYSE: CCL) shares have drawn a wave of positive analyst commentary after the cruise operator delivered stronger-than-expected fiscal fourth-quarter results and issued 2026 earnings guidance that exceeded
Analyst Sees Continued Momentum for Rank Group Despite Payment Fraud News
Rank Group’s (LON: RNK) shares were in focus on Monday after the company disclosed it had fallen victim to a €7.1 million payment fraud at its Spanish operations. The
Mothercare Grapples with Sales and Profit Decline Amid Restructuring Efforts
Mothercare PLC (MTC), a British heritage international brand, announced its unaudited half-year results for the 26-week period ending September 27, 2025, revealing a decline in worldwide retail sales and adjusted profitabilit
Christie Group Shares Jump: Set to Exceed Expectations After Strong Q4 Surge
Christie Group plc (CTG.L) shares jumped at the open on Tuesday, after the company said it anticipates a robust full-year performance, exceeding previous forecasts, fueled by unexpectedly strong trading in the final three mon
Concurrent Technologies Expands Capacity Despite Planning Delays; Shares Gain
Concurrent Technologies (AIM: CNC) saw its shares edge around 1.1% higher Tuesday morning after the company announced a revised plan to expand its headquarters and manufacturing facilities in Colchester.
Pets at Home Appoints James Bailey as CEO, Shares Rise
Pets at Home Group Plc (PETS) has announced the appointment of James Bailey as its new Chief Executive Officer, effective March 30, 2026. Bailey, formerly Managing Director
FTSE 100 Declines as European Markets Mixed; GSK, HBR Fall
The FTSE 100 fell 0.5% on Monday, underperforming mixed moves across European markets. Germany’s DAX edged 0.1% higher, while France’s CAC 40 declined 0.3%. The pan-Europe
Harbour Energy Shares Slide After $3.2bn LLOG Deal Establishes ‘Top-Tier Position’
Harbour Energy (LON: HBR) shares fell on Monday after the oil and gas producer announced a $3.2bn acquisition of LLOG Exploration, a move that marks its entry into the deepwater U.S. Gulf of America.
GSK Shares Edge Lower: Pharma Firm to Lower U.S. Drug Prices
GSK (LON: GSK) shares have edged lower on Monday after the pharmaceutical group said on Friday that it had reached an agreement with the U.S. government to reduce the cost of certain prescription medicines and expand access t
IG Group Holdings Navigates Board Chair Transition – What it Means for Investors
IG Group Holdings plc (LON:IGG) has provided an update regarding the succession of its Board Chair, a development closely watched by markets for its potential impact on the company's strategic direction.
LondonMetric Property Executes £91 Million in Strategic Asset Transactions
LondonMetric Property Plc (LON: LMP) has announced a series of strategic investment activities totaling £91 million, signaling a clear shift in its portfolio composition.
AstraZeneca’s Lung Cancer Trial Fails to Meet Primary Endpoint – What’s Next?
AstraZeneca (AZN) shares are facing scrutiny following the announcement that its Phase III LATIFY trial, evaluating ceralasertib in combination with Imfinzi (durvalumab), did not meet its primary endpoint of overall survival